Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 A pharmacological approach to gastric acid inhibition.

Literature DB >> 16335853

A pharmacological approach to gastric acid inhibition.

Abstract

Proton pump inhibitors have changed our approach to gastric acid-related diseases. They are much more potent acid inhibitors than H2-antagonists and exhibit a sophisticated mechanism of action. The present review analyses the general pharmacology of proton pump inhibitors and differentiates the specific characteristics of the various compounds that belong to this family. Special emphasis has been placed in describing the clinical implications of such differences and the potential importance for adverse effects.

Entities: Chemical Disease Gene

Mesh：

Substances：

Year: 2005 PMID： 16335853 DOI： 10.2165/00003495-200565001-00003

Source DB: PubMed Journal: Drugs ISSN： 0012-6667 Impact factor: 9.546

14 in total

1. Oral esomeprazole vs. intravenous pantoprazole: a comparison of the effect on intragastric pH in healthy subjects.

Authors: D Armstrong; D Bair; C James; L Tanser; S Escobedo; K Nevin
Journal: Aliment Pharmacol Ther Date: 2003-10-01 Impact factor: 8.171

Review 2. Pantoprazole: an update of its pharmacological properties and therapeutic use in the management of acid-related disorders.

Authors: Susan M Cheer; Amitabh Prakash; Diana Faulds; Harriet M Lamb
Journal: Drugs Date: 2003 Impact factor: 9.546

Review 3. Rabeprazole: a review of its use in acid-related gastrointestinal disorders.

Authors: H D Langtry; A Markham
Journal: Drugs Date: 1999-10 Impact factor: 9.546

4. Pharmacokinetics and pharmacodynamics of esomeprazole, the S-isomer of omeprazole.

Authors: T Andersson; K Röhss; E Bredberg; M Hassan-Alin
Journal: Aliment Pharmacol Ther Date: 2001-10 Impact factor: 8.171

Review 5. Rabeprazole: an update of its use in acid-related disorders.

Authors: C I Carswell; K L Goa
Journal: Drugs Date: 2001 Impact factor: 9.546

6. Gastric acid control with esomeprazole, lansoprazole, omeprazole, pantoprazole, and rabeprazole: a five-way crossover study.

Authors: Philip Miner; Philip O Katz; Yusong Chen; Mark Sostek
Journal: Am J Gastroenterol Date: 2003-12 Impact factor: 10.864

Review 7. Lansoprazole. A review of its pharmacodynamic and pharmacokinetic properties and its therapeutic efficacy in acid-related disorders.

Authors: L B Barradell; D Faulds; D McTavish
Journal: Drugs Date: 1992-08 Impact factor: 9.546

Review 8. Continuing development of acid pump inhibitors: site of action of pantoprazole.

Authors: J M Shin; M Besancon; C Prinz; A Simon; G Sachs
Journal: Aliment Pharmacol Ther Date: 1994 Impact factor: 8.171

Review 9. Omeprazole. An update of its pharmacology and therapeutic use in acid-related disorders.

Authors: M I Wilde; D McTavish
Journal: Drugs Date: 1994-07 Impact factor: 9.546

Review 10. Drug interaction studies with esomeprazole, the (S)-isomer of omeprazole.

Authors: T Andersson; M Hassan-Alin; G Hasselgren; K Röhss
Journal: Clin Pharmacokinet Date: 2001 Impact factor: 5.577

2 in total

1. Effectiveness of salivary stimulation using xylitol-malic acid tablets as coadjuvant treatment in patients with gastro-oesophageal reflux disease: early findings.

Authors: I Sánchez-Blanco; M Rodríguez-Téllez; J-R Corcuera-Flores; C González-Blanco; D Torres-Lagares; M-Á Serrera-Figallo; G Machuca-Portillo
Journal: Med Oral Patol Oral Cir Bucal Date: 2020-11-01

2. Gastroprotective activity of (E)-ethyl-12-cyclohexyl-4,5-dihydroxydodec-2-enoate, a compound isolated from Heliotropium indicum: role of nitric oxide, prostaglandins, and sulfhydryls in its mechanism of action.

Authors: Yaraset López-Lorenzo; María Elena Sánchez-Mendoza; Daniel Arrieta-Baez; Adriana Guadalupe Perez-Ruiz; Jesús Arrieta
Journal: Pharm Biol Date: 2022-12 Impact factor: 3.889

2 in total